InMed Pharmaceuticals (INM) Profit After Tax Growth (5y) (2024 - 2026)

InMed Pharmaceuticals (INM) Profit After Tax Growth (5y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.05 Bn	43.08 Bn	-
2	Teva Pharmaceutical Industries	43.39 Bn	39.74 Bn	2.15 Bn
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.78 Bn	22.99 Bn	5.10 Bn
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn
8	Elanco Animal Health	11.92 Bn	11.39 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	9.99 Bn	-
10	InMed Pharmaceuticals	6.64 Mn	1.40 Mn	-

Download Data